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Objective: Atheromatous aortic disease is a risk factor for excessive mortality and
stroke in patients undergoing coronary artery bypass grafting. Outcomes of off-
pump coronary artery bypass grafting and coronary artery bypass grafting with
cardiopulmonary bypass in patients with severe atheromatous aortic disease were
compared by propensity case-match methods.
Methods: Routine intraoperative transesophageal echocardiography identified 985
patients undergoing isolated coronary artery bypass grafting with severe atheroma-
tous disease in the aortic arch or ascending aorta. Off-pump coronary artery bypass
grafting was performed in 281 patients (28.5%). Propensity matched-pairs analysis
was used to match patients undergoing off-pump coronary artery bypass grafting (n
 245) with patients undergoing coronary artery bypass grafting with cardiopul-
monary bypass.
Results: Univariate analysis revealed decreased hospital mortality (16/245, 6.5% vs
28/245, 11.4%; P  .058) and stroke prevalence (4/245, 1.6% vs 14/245, 5.7%;
P .03) in off-pump coronary artery bypass grafting compared with coronary artery
bypass grafting with cardiopulmonary bypass. Freedom from any postoperative
complication was higher in off-pump coronary artery bypass grafting compared with
coronary artery bypass grafting with cardiopulmonary bypass (226/245, 92.2% vs
196/245, 80.0%; P  .001). Multivariable analysis of preoperative risk factors
showed that increased hospital mortality was associated with coronary artery bypass
grafting with cardiopulmonary bypass (odds ratio  2.7; P  .01), fewer grafts
(P  .05), acute myocardial infarction (odds ratio  11.5; P  .001), chronic
obstructive pulmonary disease (odds ratio 2.4; P .03), previous cardiac surgery
(odds ratio  10.2, P  .05), and peripheral vascular disease (odds ratio  2.1;
P  .05). Cardiopulmonary bypass was the only independent risk factor for stroke
(odds ratio  3.6, P  .03). At 36 months’ follow-up, comparable survival was
observed in the off-pump coronary artery bypass grafting and coronary artery
bypass grafting with cardiopulmonary bypass groups (74% vs 72%). Multivariable
analysis revealed that renal disease (P  .001), advanced age (P  .001), previous
myocardial infarction (P  .03), and lower number of grafts (P  .02) were
independent risks for late mortality.
Conclusions: Patients with severe atherosclerotic aortic disease who undergo off-
pump coronary artery bypass grafting have a significantly lower prevalence of
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hospital mortality, perioperative stroke, and overall complications than matched
patients who underwent coronary artery bypass grafting with cardiopulmonary
bypass. Routine intraoperative transesophageal echocardiography identifies severe
atheromatous aortic disease and directs the choice of surgical technique.
Severe atheromatous aortic disease has beenidentified as an independent risk factor forboth mortality and stroke1-3 in patients under-going coronary revascularization and can beassociated with an operative mortality as highas 14.3%.4 Different surgical techniques have
been suggested to minimize the risks of neurologic events in
these patients. Such techniques, depending on the location
of the disease, have included a “no-touch” technique of the
ascending aorta,5 internal aortic occlusion,6 use of a long
aortic cannula,7 modification in sites of cannulation and
proximal anastomoses,8,9 aortic arch endarterectomy,10,11
and graft replacement of the ascending aorta.12 More re-
cently, intra-aortic filtration has been reported to reduce
adverse neurologic events.13
Off-pump coronary artery bypass (OPCAB) grafting has
gained worldwide popularity14-17 and has been associated
with less perioperative intra-aortic balloon usage, less post-
operative atrial fibrillation, and shorter lengths of stay in the
hospital or intensive care unit.15 Nonrandomized compara-
tive studies have shown significant reductions in both mor-
tality and major neurologic events with the OPCAB tech-
nique.18-22 However, previous studies using the propensity
case-match methodology have not demonstrated a survival
benefit for OPCAB compared with cardiopulmonary bypass
(CPB)23,24 or have instead focused on global “high-risk”
patients.25
By the use of transesophageal echocardiography (TEE),
we routinely intraoperatively evaluate all patients undergo-
ing coronary revascularization for the presence of athero-
matous aortic disease. Such an approach has allowed us to
demonstrate that grade and location of aortic atherosclerotic
disease are associated with increased perioperative neuro-
logic risk.10,26,27 A prior nonmatched comparative study
also demonstrated an association between the OPCAB tech-
nique and improved outcomes.28 The current study uses
propensity case matching to explore the relationship be-
tween surgical revascularization technique and outcomes in
the subset of patients with severe atheromatous aortic dis-
ease.
Methods
Between June 1993 and October 2002, a total of 5976 consecutive
patients underwent isolated coronary artery bypass grafting
(CABG) at our institution. All patients underwent routine intraop-
erative TEE evaluation of the aorta. The degree of atherosclerotic
disease was graded according to the system developed by Katz and
coworkers:26 grade 1  absence of significant disease, grade 2 
extensive intimal thickening, grade 3  sessile atheroma less than
5 mm thick, grade 4  protruding atheroma more than 5 mm, and
grade 5  mobile atheroma. Significant atheromatous disease
(grade 4 or 5) of the ascending aorta or aortic arch as diagnosed by
intraoperative TEE was found in 985 of these patients (16.5%). If
ascending aortic disease was demonstrated on TEE, epiaortic scan-
ning was routinely performed.27,29 In the presence of severe as-
cending aortic atherosclerosis, echocardiography and manual pal-
pation (typically with inflow occlusion) were performed to
evaluate potential sites for arterial cannulation and crossclamp
application; in these patients, proximal anastomoses were per-
formed during a single clamp application. If a crossclamp could
not be safely applied, the distal anastomoses were performed under
fibrillation (13% of the CPB-CABG group).
In the identified patient subset with grade 4 or 5 atheromatous
disease of the ascending aorta or aortic arch, 281 patients under-
went OPCAB surgery and 704 patients underwent CPB-CABG. To
reduce the influence of selection on the comparison of outcome,
we used propensity-score pairwise matching of patients undergo-
ing off-pump surgery to the pool of available patients undergoing
on-pump surgery as has been described.24,30,31 The propensity
matched-pairs analysis is a balancing score method that attempts to
correct bias in patient selection by creating equivalent risk groups
for analysis. The propensity score provides the probability that
patients received a particular treatment, in this case OPCAB.
Patients from the off-pump and on-pump groups were matched by
using this propensity score so that the treatment outcomes could be
compared.
By use of multivariable logistic regression, we determined the
independent factors associated with group membership (OPCAB
vs CPB-CABG). These factors (Appendix 1) included ejection
fraction less than 30%, urgent or emergency operation, previous
myocardial infarction (MI), prior stroke or cerebrovascular dis-
ease, previous cardiac operation, and number of grafts performed.
After this parsimonious model was created, we established a
saturated model by adding other important clinical variables.
These factors included renal insufficiency, age, gender, congestive
heart failure, diabetes, peripheral vascular disease, calcified as-
cending aorta, and chronic obstructive pulmonary disease. Finally,
patients in the on-pump group were matched to patients in the
off-pump group by use of a greedy matching strategy.32,33 The
matched cohorts of 245 patients each are the subjects of this study.
Patient data were prospectively collected by trained nurse clini-
cians according to the definitions used by the New York State
Cardiac Surgery Reporting Form, an independently audited data
collection instrument used to record and analyze all cardiac sur-
gery performed in New York State. According to this nomencla-
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ture, stroke is defined as a permanent new focal neurologic deficit
that occurs anytime during the postoperative hospitalization and/or
new findings on computed tomography or magnetic resonance
imaging. Follow-up survival was ascertained from the Social Se-
curity Death Index.34
Statistical models were formed and analyzed on a computer
using SPSS and SAS statistical software (SPSS, Inc, Chicago, Ill;
SAS Institute Inc, Cary, NC). The chi-square test was used to
calculate the probability value for the comparison of dichotomous
variables. Fisher’s exact test (2-sided) was used when the number
in any cell was less than 5. Survival analysis was performed using
life table methodology, and differences were tested with a Wil-
coxon statistic. Values are expressed as the mean  SD unless
otherwise indicated.
Results
Table 1 lists the patients’ clinical characteristics and risk
factors by operative type. Preoperative characteristics of
patients in the CPB-CABG and OPCAB groups were fully
matched and balanced in terms of risk factor distribution,
with a propensity score difference of 0.003 between groups.
Most of the patients underwent urgent or emergency oper-
ations, one fifth were octogenarians, and approximately one
third had a history of stroke or cerebrovascular disease.
Emergency operations occurred in 40 patients (16.3%) of
the OPCAB group and in 33 patients (13.5%) of the CPB-
CABG group (P  .37). The intraoperative and postopera-
tive data are summarized in Table 2. The mean number of
bypass grafts was 2.3 0.8 in both groups. Overall hospital
mortality in the OPCAB group was 6.5% (16/245) versus
11.4% (28/245) in the CPB-CABG group (2  3.6, P 
.058). Reoperation for bleeding, intensive care unit length
of stay, hospital length of stay, and occurrence of any major
complication were significantly reduced with the OPCAB
technique. By comparison, all the patients in the CABG
group during the same time period (n  5976) had a raw
mortality of 3.7% and a stroke complication of 1.9%.
Multivariable analysis revealed (Table 3) that the CPB-
CABG technique, fewer grafts, acute MI, chronic obstruc-
tive pulmonary disease, previous cardiac operations, and
peripheral vascular disease were significantly associated
with increased hospital mortality; the operative year and
surgeon had no impact on mortality.
Stroke occurred in 5.7% of the patients in the CPB-
CABG group and in 1.6% of the patients in the OPCAB
group (P  .03). Multivariable analysis revealed that CPB
was the only independent risk factor for stroke (odds ratio
3.6, confidence interval  1.2-11.0, P  .03). Previous
stroke or cerebrovascular disease were borderline signifi-
cant risk factors for perioperative stroke (odds ratio  2.5,
confidence interval  1.0-6.5, P  .06). Table 2 demon-
strates that compared with the patients in the CPB-CABG
group, patients in the OPCAB group underwent fewer re-
explorations for bleeding, had shorter intensive care unit
stays, and had a shorter total hospital length of stay. A
higher percentage of patients in the OPCAB group were free
from any major complication. Fewer patients in the OPCAB
group received red blood cell transfusions than patients in
the CPB-CABG group (68.4% vs 86.9%; P  .001). In
addition, less total blood bank costs were associated with
patients in the OPCAB group (median $1200 vs $3132; P
.001).
A 3-year follow-up of the hospital survivors revealed no
difference in mortality between the OPCAB and CPB-
CABG groups (Figure 1). Cox regression analysis of these
patients revealed that renal disease, previous MI, advanced
age, and fewer grafts were the significant risks for death
(Table 4). The operative technique (OPCAB or CPB-
CABG) had no significant impact on late survival.
Discussion
Survival Benefit
The current study shows that the OPCAB technique in
patients with severe atheromatous aortic disease is associ-
ated with a lower risk of death, stroke, and all complications
when compared with conventional CABG. Although our
initial univariate analysis demonstrated an equivocal signif-
icance (P  .058), the subsequent multivariable analysis
demonstrated a very strong decrease in mortality associated
with the OPCAB technique (P  .01). Most previous stud-
ies of selected high-risk patient groups (patients with prior
neurologic events, prior cardiac surgery, impaired left ven-
tricular function, or advanced age) undergoing CABG have
failed to clearly demonstrate a significant difference in
TABLE 1. Comparison of patient preoperative clinical




n  245 P value
Mean age (y)  SD 73 8 73 9 .9
Age  80 y 55 (22.4%) 50 (20.4%) .58
Female gender 80 (32.7%) 73 (29.8%) .50
Urgent or emergency operation 212 (86.5%) 224 (91.4%) .08
Renal disease 33 (13.5%) 29 (11.8%) .59
History of stroke or
cerebrovascular disease
75 (30.6%) 76 (31.0%) .92
Preoperative IABP 8 (3.3%) 3 (1.2%) .22
EF  30% 40 (16.3%) 43 (17.6%) .72
CHF 74 (30.2%) 75 (30.6%) .92
Acute MI 13 (5.3%) 5 (2%) .09
PVD 72 (29.4%) 79 (32.2%) .49
Previous cardiac operation 20 (8.2%) 14 (5.7%) .29
Diabetes 72 (29.4%) 75 (30.6%) .77
COPD 45 (18.4%) 45 (18.4%) 1.0
CABG, Coronary artery bypass graft; COPD, chronic obstructive pulmonary
disease; EF, ejection fraction; IABP, intra-aortic balloon pump; MI, myo-
cardial infarction; OPCAB, off-pump coronary artery bypass; PVD, periph-
eral vascular disease; CPB, cardiopulmonary bypass; CHF, congestive
heart failure.
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operative mortality between OPCAB and CPB.35-37 Al-
though the group from Harefield, United Kingdom,18,22
reported lower mortality with the OPCAB technique in both
high-risk (EuroSCORE5) and elderly patients, these stud-
ies did not involve randomization or case matching. A
recent propensity case-matched study reported superior hos-
pital outcome with OPCAB surgery in high-risk patients,
but the matching did not include age or number of grafts
performed,25 factors that can additionally affect outcome.28
Severe atherosclerosis of the ascending aorta and arch
has been shown to increase the risk of both mortality and
perioperative stroke in patients undergoing CABG.1,26,38
The hospital mortality in our CPB group of 11.4% was
comparable to the 14.3% reported by Wareing and col-
leagues4 for patients with ascending aortic disease not re-
ceiving the aggressive approach of graft replacement of the
aorta. It should be noted, therefore, that the difference in
hospital mortality between the OPCAB and CPB techniques
presented here does not reflect excessive mortality in the
CPB group, but rather a reduction in mortality in the OP-
CAB group. We believe that this is the first study to dem-
onstrate a hospital survival benefit for the OPCAB tech-
nique in this specific high-risk patient subset, validating
previous observations in non–case-matched studies.28 In
addition, this study reinforces the fact that clinically signif-
icant atheromatous disease of the aorta is located in the
transverse arch, without necessarily affecting the ascending
aorta.27
Our data also demonstrate equivalent postdischarge sur-
vival between the OPCAB and CPB groups. This equivalent
midterm follow-up is similar to previous reports of both
low-risk39 and high-risk patients.25 Renal dysfunction, pre-
vious MI, advanced age, and fewer bypass grafts were the
only significant risks for late death.
Neurologic Impact
The reduction in stroke prevalence associated with use of
the OPCAB technique in our study is comparable to that in
previous non–case-matched studies19,21 and in 1 propensity
case-matched study of a nonselective group of patients.23
The present findings, however, contrast with those of the
TABLE 4. Multivariable analysis of postdischarge survival
Risk factor Exp B 95% CI P value
Age — — .001
Lower number of graft — — .02
Renal disease 2.7 1.7–4.5 .001
Previous MI 1.7 1.1–2.7 .03
CPB 1.0 0.6–1.6 .87





(n  245) P value
Bypass time (min)  SD — 97 44
Crossclamp time* (min)  SD — 53 31
Number of grafts distal anastomoses (mean  SD) 2.3 0.8 2.3 0.8 .5
Hospital mortality (%) 16 (6.5%) 28 (11.4%) .058
Reoperation for postoperative bleeding (%) 1 (0.4%) 8 (3.3%) .04
Deep wound infection (%) 1 (0.4%) 2 (0.8%) .62
Sepsis (%) 2 (0.8%) 8 (3.3%) .11
New renal failure (%) 6 (2.4%) 9 (3.7%) .6
Prolonged respiratory failure (%) 13 (5.3%) 23 (9.4%) .08
Stroke (all neurologic events) (%) 4 (1.6%) 14 (5.7%) .03
Length of ICU stay (median) 1 1 .001
(mean  SEM) 2.8 0.4 4.6 1.0
Length of hospital stay 7 9 .001
Complication-free (%) 226 (92.2%) 196 (80.0%) .001
ICU, Intensive care unit.
*Thirty-two patients (13%) had CPB using fibrillation without crossclamp application.
TABLE 3. Multivariable analysis of hospital mortality
Risk factor Exp B 95% CI P value
Age — — .17
Fewer number of grafts
performed
— — .05
Acute MI 11.5 3.5–38.5 .001
CPB-CABG 2.7 1.2–5.9 .01
COPD 2.4 1.1–5.1 .03
History of renal disease 2.2 0.9–0.5 .08
PVD 2.1 1.0–4.5 .05
CHF 2.0 0.89–4.5 .09
EF  30% 0.5 0.2–1.2 .13
Previous cardiac surgery 10.2 1.0–108.9 .05




Surgeon identity and operative year were not significant risk factors for
mortality. CI, Confidence interval.
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propensity case-matched study of Sabik and colleagues,24
which was unable to demonstrate a reduction in stroke with
OPCAB surgery. Nevertheless, close examination of
Sabik’s data reveals equivalent neurologic outcomes in the
OPCAB and CABG groups despite the OPCAB group’s
significantly greater prevalence of pulmonary vascular dis-
ease and history of stroke. A positive neurologic impact in
their study may have been underestimated by such risk
factors that were not included in their propensity matching
but are generally associated with higher neurologic compli-
cation prevalence.
We identified patients with severely atheromatous as-
cending aortas or arches for this study on the basis of our
previous work indicating that the risk of perioperative neu-
rologic complications in CABG and other operative proce-
dures is directly related to the severity of the aortic ather-
oma as graded by TEE.10,40 It is known that the stroke
prevalence is still high for patients with moderate or severe
ascending aortic disease when minor modifications in sur-
gical strategy with CPB (guided by epiaortic scanning) are
used,4 and that the mortality is excessive (24.8%) for pa-
tients who do have a stroke.41 Therefore, although the
previously mentioned avoidance or limited manipulation of
the ascending aorta in patients with severe atheromatous
aortic disease is important,42 there stills remains significant
risk. We speculate that atheromatous disease in aortic arch
disease is a contributor to atheroemboli from CPB-induced
flow-pattern changes.7 Although limited atherectomy or
graft replacement has its advocates,12 we would argue that
in these patients “the only way to win is not to play.” In this
high-risk patient subset, avoidance of CPB serves the pa-
tients better, as our results demonstrate.
Limitations
Although patient data were collected prospectively, a limi-
tation of this study is that the decision to perform OPCAB
surgery was not randomized. However, by using the pro-
pensity score-matching analysis, we attempted to minimize
bias between the OPCAB and the CPB-CABG groups.43,44
Indeed, the CPB and OPCAB groups had an approximately
equal distribution of all significant preoperative variables.
However, a limitation of this analytic technique is that it
accounts for only identified variables. Although we made
every attempt to acknowledge all clinically significant vari-
ables, it is possible that an effect may exist from an unquan-
tified variable. This series also encompasses our “learning
curve” for OPCAB surgery, including our initial experi-
ences.
Conclusions
Intraoperative TEE is indicated in all patients undergoing
operative coronary revascularization because it allows
timely identification of patients at high risk for a neurologic
event associated with CPB. Use of the OPCAB technique in
these high-risk patients minimizes hospital mortality, neu-
rologic complications, and overall morbidity.
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APPENDIX 1
Multivariable analysis of preoperative risk factors associated with
OPCAB in 985 patients
Risk factor OR 95% CI P value
EF  30% 2.3 1.5–3.7 .01
Urgent/emergency operation 2.5 1.6–3.8 .01
Previous MI 0.6 0.4–0.8 .01
Increased number of grafts performed 0.3 0.3–0.4 .01
Previous cardiac surgery 0.4 0.2–0.8 .01
History of stroke or cerebrovascular
disease
1.5 1.1–2.3 .01
The following factors were not significantly associated with group mem-
bership but were added to create the saturated model: renal insufficiency,
age, gender, congestive heart failure, diabetes, peripheral vascular dis-
ease, calcified ascending aorta, and chronic obstructive pulmonary dis-
ease.
EF, Ejection fraction; MI, myocardial infarction; OPCAB, off-pump coronary
artery bypass; OR, odds ratio; CI, confidence interval.
Discussion
Dr Nicholas T. Kouchoukos (St Louis, Mo). In this study
comparing off-pump and on-pump surgery for patients with cor-
onary artery disease, Dr Sharony and his colleagues examined a
subset of patients who are known to be at increased risk for a
postoperative neurologic event: those with severe atherosclerosis
of the ascending aorta or the aortic arch that has been identified by
intraoperative TEE. Using propensity matched-pairs analysis, they
demonstrated a lower hospital mortality, a lower prevalence of
stroke, and a greater freedom from any postoperative complication
among the patients in the off-pump group. They thus provided new
and important information indicating that OPCAB grafting may be
of particular benefit in this high-risk subset of patients with coro-
nary artery disease. I want to focus my subsequent comments on
the complication of stroke. Although propensity matched-pairs
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analysis was used in patients with comparable preoperative char-
acteristics, which certainly strengthens the validity of the analyses
and the conclusions, this was, nevertheless, a retrospective study
and is therefore subject to the usual criticisms that are leveled at
such studies.
Intraoperative TEE was used to identify the presence of severe
atherosclerosis in this study, and the New York University group
pioneered the use of TEE in patients undergoing cardiac surgery.
However, several studies, including one from our institution, have
demonstrated that TEE underestimates the prevalence and severity
of aortic atherosclerosis in the ascending aorta when compared
with epiaortic scanning. Although the article indicates that epiaor-
tic scanning was routinely performed when aortic disease was
identified by TEE, and this was presumably done for corrobora-
tion, no information was provided as to how this information from
scanning was used. Is it possible that patients with severe aortic
disease were excluded from the study group because the severity
was underestimated because only TEE was used to identify its
presence?
There was no mention of specific interventions to prevent or
minimize the risk of atheroembolization once severe atherosclero-
sis was detected for either of the 2 therapeutic groups. It is
common in many practices, including our own, to make modifi-
cations in technique, such as the use of alternative sites for can-
nulation and clamping, use of only pedicled arterial grafts, resec-
tion and replacement of the severely atherosclerotic aorta, and
others, when severe atherosclerosis is detected. Were any such
interventions used in either group?
The authors demonstrated in their multivariate analysis that use
of CPB was the only independent risk factor for stroke. Is it
possible that other variables related to surgical technique that were
not included in the analyses could have contributed to the differ-
ences in stroke?
As Dr Blackstone and others have pointed out, propensity score
methodology is seriously degraded when other important variables
influencing selection are not collected.
Although atherosclerotic disease is a major risk factor for
stroke, other important risk factors for postoperative stroke also
exist. Highly obstructive carotid artery disease documented by
preoperative duplex scanning or angiography and postoperative
atrial fibrillation are 2 of these. From the presentation and from my
review of the article, these 2 variables were not entered into the
model. Could differences in the prevalence of these 2 variables
account for some or all of the differences in the stroke rates?
Although the controversy regarding the beneficial effect of
OPCAB grafting on the prevalence of postoperative stroke has not
been resolved, Dr Sharony and his colleagues have provided
highly suggestive evidence that it may be beneficial in patients
who are known to be at increased risk for stroke because of the
presence of severe aortic atherosclerosis, and they are to be com-
mended. But perhaps it is time for a large, multicenter, randomized
trial to establish conclusively whether OPCAB will substantially
reduce the presence of this important complication. Because the
mortality and stroke rates are increased for patients with aortic
atherosclerosis compared with the general population, and this was
shown in their study and in our studies as well using epiaortic
scanning, it should be possible to demonstrate substantial differ-
ences, if they exist, without extraordinarily large numbers of
patients.
Dr John W. Hammon, Jr (Winston-Salem, NC). I also con-
gratulate the New York University group for their careful analysis
of their data. I think that is something that we all need to do more
often.
I would like to ask 1 question, and it is a variation on a theme
of Dr Kouchoukos’ third question regarding variables that might
be overlooked or missed by your propensity-matched analysis.
Your group was analyzed during the entire decade of the 1990s,
and most OPCAB surgery was performed in the latter part of the
1990s. Are you comparing OPCAB operations that were per-
formed in the late 1990s with coronary bypass operations per-
formed on-pump in the early 1990s when some of the tools to
identify aortic atherosclerosis, to avoid it, and other techniques to
avoid intraoperative embolization, were present?
Dr Lawrence I. Bonchek (Lancaster, Pa). It would be difficult
to add anything to Dr Kouchoukos’ thorough analysis, but when
OPCAB is compared with operations performed with CPB, neither
of those procedures should be treated as a commodity. Everyone
performs operations differently, and I would also make a plea for
you to tell us more about your technique. For example, did you
ever perform operations with CPB without any clamping of the
aorta, by doing proximal anastomoses to the aorta with a brief
period of circulatory arrest and distal anastomoses without cardio-
plegia but with ventricular fibrillation and local control of the
grafted artery? That is the approach we take with bad aortas, and
with those maneuvers we find the stroke rates on pump to be quite
acceptable.
Dr Vivek Rao (Toronto, Ontario, Canada ). I echo what the
previous discussants have said. It was not clear in your presenta-
tion if, in your on-pump group, other procedures were done in
addition to bypass surgery—most notably that of replacement of
the ascending aorta. Clearly, that procedure is going to increase
your perioperative stroke rate; however, it might reduce the long-
term risk of ascending aortic atheroma.
Perhaps the lack of difference you saw in your survival curves
was because atheroma was addressed at the initial operation in the
on-pump group, and that group was at lower risk for future stroke
events. Whereas in the OPCAB group, you really did not do
anything about the patients’ aortic atheroma, and that might be one
of the causes of late events in these patients.
Dr O. Wayne Isom (New York, NY). I enjoyed the article very
much. One other question. We found a number of years ago at
New York Hospital that with atherosclerotic aortas there was a big
difference in the incidence of stroke rate with the varying of
pressures. What kind of pressures did you run during CPB?
Dr Sharony. Thank you to all the discussants for their com-
ments, and I will try to answer question by question.
First, we consider intraoperative TEE the primary tool to iden-
tify severe atheromatous disease of the arch and the ascending
aorta. Everybody knows that TEE has some limitations in the distal
part of the ascending aorta because of the interposition of the
trachea and the main stem bronchus. However, it has been shown
in our institution by Tissot and Kanchuger that TEE combined
with palpation, which by itself has a low sensitivity, results in 0
false negatives. This means if we perform TEE and palpation and
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both are negative, we are confident that there is no severe ather-
omatous disease of the ascending aorta. Yes, although there is low
probability that TEE alone may miss some disease, our combined
evaluation, especially with the capability of the newer multiplane
TEE probes, decreases the chance that we will miss significant
lesions in the ascending aorta. Regarding specific interventions
used in either group to minimize the risk of atheroembolism, in the
absence of ascending aortic disease, we perform the proximal
anastomoses before CPB and the distal anastomoses during a
single crossclamp. However, when there is concern of atheroma-
tous disease in the ascending aorta and CPB is used, epiaortic
scanning is performed for disease localization, and the proximals
and distals are created during the single aortic crossclamp. Cur-
rently, if we identify severe ascending atheromatous aortic disease,
we apply a no-touch technique to the aorta with the OPCAB
technique. This can be accomplished with in situ arterial grafts
serving as inflow for secondary bypass grafts. Again, I stress that
the majority of patients in this report had severe atheromatous
disease limited to the transverse arch. The implication from this
study is that when CPB is used, embolic material originates from
the arch and maneuvers to avoid ascending aortic disease will not
have any impact in these patients.
Regarding other variables relating to the surgical techniques
that were not included in the analysis (disregarding that the only
predictor by multivariate analysis was CPB-CABG as a predictor
for stroke), we entered all the parameters in our multivariate
analysis, and the only one found to be significant was CPB-CABG.
Regarding obstructive carotid disease and atrial fibrillation, we did
match patients on the presence of obstructive carotid disease;
however, we did not match for preoperative atrial fibrillation.
Cerebrovascular disease includes previous stroke or significant
cerebrovascular disease.
With regard to arterial perfusion pressure, we routinely main-
tain a perfusion pressure of approximately 70 mm Hg during
bypass, and we consider this extremely important in chronically
hypertensive patients.
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